» Articles » PMID: 25701816

Enteric Hyperoxaluria: an Important Cause of End-stage Kidney Disease

Overview
Date 2015 Feb 22
PMID 25701816
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperoxaluria is a frequent complication of inflammatory bowel diseases, ileal resection and Roux-en-Y gastric bypass and is well-known to cause nephrolithiasis and nephrocalcinosis. The associated prevalence of chronic kidney disease and end-stage kidney disease (ESKD) is less clear but may be more consequential than recognized. In this review, we highlight three cases of ESKD due to enteric hyperoxaluria following small bowel resections. We review current information on the pathophysiology, complications and treatment of this complex disease.

Citing Articles

Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut-Kidney Axis.

De Sire R, La Mantia A, Bonacci L, Testa A, Guarino A, Rispo A Life (Basel). 2025; 14(12.

PMID: 39768250 PMC: 11678131. DOI: 10.3390/life14121541.


Complex system modelling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria.

Mukherjee S, Batagello C, Adler A, Agudelo J, Zampini A, Suryavanshi M bioRxiv. 2024; .

PMID: 39553961 PMC: 11565779. DOI: 10.1101/2024.10.28.620613.


Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory.

Cellini B, Baum M, Frishberg Y, Groothoff J, Harris P, Hulton S Kidney Int Rep. 2024; 9(11):3083-3096.

PMID: 39534212 PMC: 11551133. DOI: 10.1016/j.ekir.2024.08.031.


Insights into renal and urological complications of inflammatory bowel disease.

Singh A, Khanna T, Mahendru D, Kahlon J, Kumar V, Sohal A World J Nephrol. 2024; 13(3):96574.

PMID: 39351187 PMC: 11439091. DOI: 10.5527/wjn.v13.i3.96574.


From Smoothies to Dialysis: The Impact of Oxalate Nephropathy.

Samra M, Gupta I Cureus. 2024; 16(8):e67409.

PMID: 39310402 PMC: 11414766. DOI: 10.7759/cureus.67409.


References
1.
Koff S, Paquette E, Cullen J, Gancarczyk K, Tucciarone P, Schenkman N . Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Urology. 2007; 69(6):1013-6. DOI: 10.1016/j.urology.2007.02.008. View

2.
Semins M, Asplin J, Steele K, Assimos D, Lingeman J, Donahue S . The effect of restrictive bariatric surgery on urinary stone risk factors. Urology. 2010; 76(4):826-9. DOI: 10.1016/j.urology.2010.01.037. View

3.
Verani R, Nasir M, Foley R . Granulomatous interstitial nephritis after a jejunoileal bypass: an ultrastructural and histochemical study. Am J Nephrol. 1989; 9(1):51-5. DOI: 10.1159/000167935. View

4.
Caspary W . Intestinal oxalate absorption. I. Absorption in vitro. Res Exp Med (Berl). 1977; 171(1):13-24. DOI: 10.1007/BF01851584. View

5.
Clayman R, Williams R . Oxalate urolithiasis following jejunoileal bypass. Surg Clin North Am. 1979; 59(6):1071-7. DOI: 10.1016/s0039-6109(16)41985-7. View